Disc Medicine Ownership | Who Owns Disc Medicine?
Disc Medicine Ownership Summary
Disc Medicine is owned by 9.10% institutional investors, 7.82% insiders, and 83.07% retail investors. Fmr is the largest institutional shareholder, holding 14.09% of IRON shares.
IRON Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Disc Medicine | 9.10% | 7.82% | 83.07% |
| Sector | Healthcare Stocks | 42.54% | 10.83% | 46.63% |
| Industry | Biotech Stocks | 45.22% | 10.75% | 44.04% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Fmr | 4.94M | 14.09% | $326.12M |
| Atlas venture life science advisors | 2.14M | 6.12% | $141.58M |
| Blackrock funding, inc. /de | 2.02M | 5.77% | $133.43M |
| Ra capital management | 1.58M | 4.50% | $104.22M |
| Vanguard group | 1.45M | 4.13% | $95.69M |
| Frazier life sciences management | 1.44M | 4.11% | $95.06M |
| Orbimed advisors | 1.42M | 4.04% | $93.50M |
| Wellington management group llp | 1.41M | 4.03% | $93.18M |
| Price t rowe associates inc /md/ | 1.33M | 3.79% | $87.65M |
| State street | 1.05M | 2.99% | $69.09M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Atlas venture life science advisors | 2.14M | 18.81% | $141.58M |
| Foresite capital management v | 299.07K | 18.17% | $19.76M |
| Checkpoint capital | 430.00K | 9.52% | $28.41M |
| Saturn v capital management | 340.90K | 4.94% | $22.53M |
| Sio capital management | 284.79K | 4.76% | $18.82M |
| Lion point capital, lp | 10.60K | 3.98% | $700.45K |
| First turn management | 397.69K | 3.95% | $26.28M |
| Frazier life sciences management | 1.44M | 2.85% | $95.06M |
| Palo alto investors lp | 224.30K | 2.74% | $14.82M |
| Logos global management lp | 450.00K | 2.67% | $29.74M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Fmr | 4.94M | 0.02% | 1.69M |
| Vestal point capital, lp | 500.00K | 1.49% | 360.00K |
| Goldman sachs group | 529.08K | 0.00% | 303.23K |
| First light asset management | 231.19K | 1.44% | 231.19K |
| Catalio capital management, lp | 216.53K | 2.65% | 185.87K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Paradigm biocapital advisors lp | 247.72K | 0.47% | -963.25K |
| Bain capital life sciences investors | - | - | -583.50K |
| Bioimpact capital | - | - | -346.40K |
| Logos global management lp | 450.00K | 2.67% | -250.00K |
| Atlas venture life science advisors | 2.14M | 18.81% | -241.84K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| First light asset management | 231.19K | 1.44% | 231.19K | $15.28M |
| Timessquare capital management | 182.17K | 0.17% | 182.17K | $12.04M |
| Hudson bay capital management lp | 102.19K | 0.02% | 102.19K | $6.75M |
| American century companies | 27.94K | 0.00% | 27.94K | $1.85M |
| Jane street group | 21.27K | 0.00% | 21.27K | $1.41B |
Sold Out
| Holder | Change |
|---|---|
| Ifp advisors | -1.00 |
| Parallel advisors | -4.00 |
| Amundi | -5.00 |
| Corecap advisors | -9.00 |
| Stephens consulting | -10.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2025 | 51 | -66.45% | 3,188,170 | -90.64% | 9 | 0.10% | 26 | -73.20% | 13 | -63.89% |
| Jun 30, 2025 | 151 | -4.43% | 34,062,461 | 12.23% | 97 | 1.17% | 96 | -4.00% | 36 | 16.13% |
| Mar 31, 2025 | 159 | 1.27% | 33,141,259 | 24.71% | 99 | 1.26% | 100 | 13.64% | 32 | -27.27% |
| Dec 31, 2024 | 157 | 16.30% | 26,575,703 | -2.98% | 88 | 1.06% | 88 | 4.76% | 44 | 69.23% |
| Sep 30, 2024 | 135 | 9.76% | 27,392,464 | -0.67% | 91 | 0.79% | 84 | 1.20% | 26 | -13.33% |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Dec 12, 2025 | Bitterman Kevin | - | Sell | $323.23K |
| Dec 15, 2025 | Bitterman Kevin | - | Sell | $2.64M |
| Dec 12, 2025 | Bitterman Kevin | - | Sell | $1.51M |
| Dec 12, 2025 | Bitterman Kevin | - | Sell | $356.62K |
| Dec 15, 2025 | Bitterman Kevin | - | Sell | $360.77K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q4 | - | 55 |
| 2025 Q3 | - | 12 |
| 2025 Q2 | - | 4 |
| 2025 Q1 | - | 65 |
| 2024 Q4 | - | 26 |
IRON Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools